hypertonicity; inner medullary collecting duct; renal; kidney; signal transduction THE 11 PROTEIN KINASE C (PKC) ISOFORMS INCLUDE conventional (␣, ␤ I , ␤ II , and ␥), novel (␦, ⑀, , and ), and atypical ( and ) isoforms (27) . Through a combination of predominantly inhibitor-based and PKC downregulation studies, several groups have broadly implicated PKC activation in hypertonic stress signaling and in the acquisition of the hypertonically stressed phenotype (16, 20, 21, 33, 36) ; other groups, however, have failed to observe PKC dependence or activation in this setting (2, 9, 10) . In a recent and thorough series of experiments, Zhuang et al. (45) described a role for the novel PKC isoforms PKC␦ and PKC⑀ in osmotic activation of the extracellular signal-regulated kinase (ERK), mitogen-activated protein kinase (MAPK) (45) . In their fibroblastic 3T3 cell model, hypertonic stress induced membrane translocation of PKC␦ and PKC⑀, as well as the conventional PKC␣ isoform. Studies with the inhibitors of novel (n)PKC, rottlerin and GF-109203X underscored a role for PKC␦ and PKC⑀ in tonicity-dependent ERK activation (45) .
In addition to activating the ERKs, however, hypertonic stress activates the p38 and c-jun N-terminal-directed kinase (JNK) families of MAPKs through activation of their respective upstream activators (reviewed in Ref. 18 ). The role of these events in the downstream activation (41) of the tonicity enhancer binding protein (TonEBP), the ubiquitous tonicity-responsive transcription factor of higher eukaryotes (26) , and in TonEBPdependent transcription (19, 32) remains incompletely understood. TonEBP was extensively and elegantly characterized in the present physiological context by Kwon et al. (reviewed in Ref 13) and cloned independently as TonEBP (26) , nuclear factor of activated T cells-5 (23) , and osmotic response element binding protein (17) . In response to hypertonic stress, TonEBP upregulation occurs at the mRNA (40) and protein levels (26) , as well as at the level of subcellular localization (41) . Signaling events influencing expression and translocation of TonEBP are receiving increasing attention. Signaling through the p38 MAPK (32) and proteasomal function (41) have been implicated in tonicity-dependent transcription or tonicity-dependent TonEBP expression; however, urea, the renal medullary solute, blocks tonicity-dependent expression of TonEBP independently of these pathways (38) . Downstream effectors of TonEBP in the renal epithelium, physiologically stressed in vivo by dramatic fluctuations in ambient tonicity, include the sorbitol-synthesizing enzyme aldose reductase and transporters of osmotically active solutes (reviewed in Ref. 3 ).
We investigated the role of novel PKC␦ and PKC⑀ isoforms in tonicity-dependent gene regulation and observed that, whereas the purportedly PKC␦-specific inhibitor rottlerin (12) potently inhibited the tonicitydependent increase in TonEBP expression at the mRNA and protein levels and inhibited TonEBP-dependent transcription of both a TonE-driven luciferase reporter gene and the physiological TonEBP effector aldose reductase, it did so in a PKC␦-independent fashion.
METHODS
General methods. Cell culture and solute treatment were performed as previously described (30, 37). The following inhibitors and stimuli (purchased from Calbiochem unless otherwise indicated) were used: 200 mM urea (Sigma); 100 mM NaCl (200 mosmol/kgH2O; Sigma); 100 nM epidermal growth factor; 100 nM 12-O-tetradecanoylphorbol 13-acetate (TPA; Sigma); 10-50 M rottlerin; 30-300 nM Go-6983, 10 M GF-109203X, 1 M Go-6976, and 50 M SB-203580. Cells receiving pretreatment with an inhibitor or solute (i.e., urea) remained exposed to the pretreatment compound for the duration of the experiment until determination of the experimental end point. Depicted data represent means Ϯ SE unless indicated; statistical significance is assigned to P Ͻ 0.05 (Excel; Microsoft). PC-12 cell lines expressing dominant negative-acting PKC isoforms were kindly provided by Drs. Thomas McMahon and Robert O. Messing and were previously described (15) . Cell lines were as follows: vectortransfected, originally designated 10-C; DN-␦, originally designated DND-21; and DN-⑀, originally designated DNE-1.
TonEBP and aldose reductase RNase protection assay. Total cellular RNA was prepared using the TriZol reagent (Life Technologies) in accordance with the manufacturer's directions. Murine TonEBP and aldose reductase partial cDNAs were previously described (38) . Plasmids were linearized with XhoI, gel-purified (QIAEX II kit; Qiagen), reconstituted in diethylpyrocarbonate-treated H2O, and used for biotinylated antisense riboprobe preparation with biotin RNA labeling mix and T7 polymerase (Boehringer Mannheim). Hybridization of probe (800 pg) with total RNA (15 g) was performed at 45°C (RPA II kit; Ambion); subsequent digestion with RNase A and T1 was performed in solution at 37°C. Detection was achieved with the BrightStar BioDetect nonisotopic detection kit (Ambion).
Reporter gene assay. The plasmid BGT-2X-Luc, based on the TonE element (25), has been previously described (37) . Cells were transfected with the plasmid of interest (as well as a lacZ expression plasmid under the control of the cytomegalovirus long terminal repeat) via electroporation; luciferase and ␤-galactosidase activities were quantitated at 6 h of treatment as previously described (6) except that, for the latter, a Luminescent ␤-Galactosidase Detection Kit II (Clontech) was used in accordance with the manufacturer's directions.
Immunoblotting. Immunoblotting, using commercially available anti-phospho-ERK and anti-phospho-p38 (Cell Signaling Technologies) was performed as previously described (42) . Anti-phospho-(Thr 505 ) PKC␦ was obtained from Cell Signaling Technologies and used in accordance with the manufacturer's directions. Rabbit polyclonal anti-TonEBP (anti-N-terminal NFAT5) was kindly provided by Drs. Cristina Lopez-Rodriguez and Anjana Rao (23) and used at 1:600 dilution in 0.075% Tween 20. For TonEBP immunoblotting, a combined mechanical and detergent-based lysis system (7) was employed to ensure nuclear disruption.
RT-PCR. RT-PCR was performed essentially as previously described, using primers selected to be specific for PKC␦, PKC⑀, PKC, and PKC isoforms and the PKC-related kinase-1 (PRK1). Primers were chosen from variable regions that lacked significant homology with other known PKC isoforms. For each isoform depicted (see Fig. 9 ), a product of only the anticipated size was generated. Optimization for each isoform was performed by varying buffer composition and pH over known increments for a total of 12 individual reactions/sample (OptiPrime; Stratagene) in accordance with the manufacturer's directions. Primer pairs for PKC isoforms (Integrated DNA Technologies, Coralville, IA) were as follows (all are listed 5Ј to 3Ј): PKC␦, 5Ј-GGA TTG CAA GCA GTC TAT GCG-3Ј and TCA CTT GGT TCA AGG CCT CAG; PKC⑀, 5Ј-TTG TCC ACA AGC GAT GTC ATG-3Ј and TGA CTT GGA TCG GTC GTC TTC; PKC, 5Ј-AGA CAT GTG TGG CCT GCA CC-3Ј and TCG ATG ACA GGC TTA AGG TCC; PKC, 5Ј-AAG CGT CGT CCA GTC TAG GTC-3Ј and CCT CGC TCA TGA AGA TAA TTC AG; and PRK1, 5Ј-CAA CGA CGA AGT TCG CTA TCC-3Ј and AAG CAC ACT CCA GTC CAG ATG C. Starting material was total RNA harvested from mIMCD3 cells (TriZol; Life Technologies).
RESULTS
Because Zhuang et al. (45) observed dependence of elements of tonicity-mediated signaling on PKC␦ in murine fibroblasts, we examined whether other aspects of tonicity signaling also require this pathway. In the best-studied model of tonicity-dependent gene regulation, transcription proceeds through upregulated interaction of TonEBP with its cognate DNA consensus element within the 5Ј-flanking region of a tonicityresponsive gene (reviewed in Ref. 13 ). mIMCD3 cells were transiently transfected with BGT-2X-Luc (44) , an expression plasmid harboring a luciferase reporter gene under the control of two tandem repeats of the BGT TonE enhancer element (35) (Fig. 1A) . As anticipated and consistent with the data of others, hypertonic stress increased TonE-dependent transcription by approximately eightfold; this effect was markedly inhibited by pretreatment of cells with the PKC␦-specific inhibitor rottlerin (12) and the nPKC and conventional (c)PKC inhibitor GF-109203X (Fig. 1B) . Cytomegalovirus long terminal repeat-driven ␤-galactosidase reporter gene activity, used for normalization, was inhibited by Ͻ20% in the presence of either NaCl or rottlerin. We were unable to assess the effect of these inhibitors on basal and tonicitydependent transcription from an enhancerless thymidine kinase promoter because this construct exhibited no detectable activity in the present model. Therefore, the effect of these inhibitors on ureainducible transcription of the immediate-early gene Egr-1 (Fig. 1C) was examined in parallel. Consistent with earlier observations (6), urea increased Egr-1 reporter gene activity by approximately sixfold; however, neither GF-109203 nor rottlerin significantly inhibited this effect (Fig. 1D ), underscoring the specificity of the effect on tonicity-dependent signaling. Next, similar studies were performed in the more physiological context of tonicity-dependent (and TonEBP-dependent) transcription of the physiological osmotic stress effector aldose reductase (Fig. 2) . Hypertonic stress (100 mM NaCl ϫ 6 h) markedly increased aldose reductase expression at the mRNA level, and this effect was substantially inhibited by pretreatment with rottlerin. GF-109203X failed to block the effect of hypertoncicity, as did the specific inhibitor of cPKC isoforms Go-6976. These data implicated an inhibitory effect of rottlerin on TonEBP action, and this pathway was examined further.
The effect of rottlerin on tonicity-dependent TonEBP expression at the mRNA level was examined via an RNase protection assay, as previously described (38) . Consistent with our earlier data and those of others, hypertonic stress increased TonEBP mRNA expression severalfold; this effect was almost completely blocked by rottlerin (Fig. 3A) . GF-109203X, however, appeared to be ineffective in this assay. The effect of these nPKC inhibitors on TonEBP expression at the protein level was explored in parallel. As anticipated and again consistent with the data of others (26, 40) , hypertonic stress modestly increased TonEBP protein abundance in whole cell lysates (Fig. 3B) . Again, strikingly similar to the mRNA expression data, rottlerin markedly inhibited basal and tonicity-inducible TonEBP expression, whereas GF-109203X failed to do so. PKC␦ and PKC⑀ have been implicated in signaling to ERK activation by hypertonicity (45) . Because the putative PKC␦ inhibitor rottlerin blocked NaCl signaling to TonE-dependent transcription, the effect of another maneuver designed to abrogate PKC␦ was examined. Phorbol ester activates all classic and nPKC isoforms, but not the atypical PKC and PKC isoforms (28) . Protracted treatment with TPA has been used to downregulate all of the TPA-responsive PKC isoforms; this treatment effectively downregulated tonicity-dependent signaling to ERK activation in 3T3 cells (45) . In the Fig. 1 . Rottlerin inhibits tonicity-dependent transcription in a tonicity enhancer (TonE)-dependent reporter gene. mIMCD3 cells were transiently transfected with BGT-2X-Luc (A) or Egr-1-Luc derived from the proximal 1.2 kb of the murine Egr-1 5Ј-flanking sequence (6, 39; C) and then pretreated with the indicated inhibitor for 60 min before exposure to hypertonic stress (100 mM NaCl ϫ 6 h; B) or urea stress (200 mM ϫ 6 h; D). Fold-induction by solute, relative to control treatment for each pretreatment pair, is indicated at the base of each bar. Gal, ␤-galactosidase; TK, thymidine kinase promoter; AP-1, activator protein-1; SREs, serum response elements; Emin, Egr-1 minimal promoter. †P Ͻ 0.05 relative to vehicle pretreatment. Fig. 2 . Rottlerin inhibits physiological TonE binding protein (TonEBP)-dependent transcription. mIMCD3 cells were subjected to RNase protection assay for the physiological TonEBP transcriptional target, aldose reductase (filled arrowhead), following control (C) or hypertonic treatment (H; NaCl 100 mM ϫ 6 h) in the presence or absence of rottlerin pretreatment (25 M ϫ 60 min), GF-109203X (10 M ϫ 60 min), or Go-6976 (1 M ϫ 30 min). Open arrowhead, control protected actin mRNA; shaded arrowheads, full-length aldose reductase and actin riboprobes (P; TonEBP is the larger of the 2). Fig. 3 . Rottlerin inhibits tonicity-dependent TonEBP expression at the mRNA and protein levels. mIMCD3 cells were pretreated with the indicated inhibitors before control treatment (C) or exposure to hypertonic stress (H; NaCl 100 mM ϫ 6 h). A: total RNA was subjected to RNase protection assay for TonEBP and actin (control) mRNA abundance. Filled arrowhead, aldose reductase riboprobe (P; lane 1) and message ( lanes 2-7) ; open arrowhead, actin riboprobe (lane 1) and mRNA (lanes 2-7) . B: whole cell protein lysate was subjected to anti-TonEBP immunoblot analysis. mIMCD3 cell model, hypertonic NaCl markedly increased ERK phosphorylation, as previously shown by us and others (2, 43) , but protracted pretreatment with TPA failed to inhibit this effect (Fig. 4A) . In similar fashion, the effect of PKC downregulation on tonicitydependent transcription was examined. It was anticipated that this rottlerin-sensitive process should be sensitive to PKC downregulation. Unexpectedly, yet consistent with the lack of effect of PKC downregulation on tonicity-dependent ERK activation, prolonged TPA treatment failed to significantly influence TonEmediated transcription (Fig. 4B) . As a positive control to confirm PKC downregulation (5), the effect of urea on transcription of the Egr-1 gene was substantially suppressed by this maneuver (Fig. 4B) .
Activation of the p38 MAPK has been implicated in TonEBP-dependent transcription, and a role for PKC␦ in tonicity-inducible ERK activation has been suggested by data obtained in nonrenal cells (45) . For these reasons, the effect of rottlerin pretreatment on tonicity-dependent ERK and p38 activation/phosphorylation was examined in mIMCD3 cells. Rottlerin exhibited a negligible effect on ERK and p38 activation under basal conditions (Fig. 5, A and B) . ERK activation by hypertonicity was in large part sensitive to rottlerin, whereas ERK activation by the phorbol ester TPA and by the peptide mitogen epidermal growth factor was not (Fig. 5A) . MAPK p38 was substantially activated only by hypertonic stress; TPA and epidermal growth factor produced no consistently demonstrable effect (Fig. 5B) . Rottlerin pretreatment only very modestly inhibited p38 activation in response to hypertonic stress. It was concluded in preliminary fashion that rottlerin was not inhibiting TonEBP signaling via an effect on p38. To corroborate these data, the effect of rottlerin was compared with that of the p38 inhibitor SB-203580 with respect to inhibition of tonicity-dependent TonEBP-mediated transcription. In mIMCD3 cells transiently transfected with BGT-2X-Luc, the effect of SB-203580 was very modest whereas the effect of rottlerin was again substantial (Fig. 5C ). In the aggregate, these data indicated that rottlerin was not operating through inhibition of a p38-dependent pathway in the present context.
Data from Zhuang et al. (45) support a role for PKC␦ in tonicity signaling. Our own data suggested that PKC␦ . Tonicity-dependent extracellular signal-regulated kinase (ERK) activation and TonE-dependent transcription do not require a phorbol ester-responsive protein kinase C (PKC) isoform. The classic and novel PKC isoforms are reported to be sensitive to protracted O-tetradecanoylphorbol 13-acetate (TPA) treatment. A: anti-phospho (P)-ERK immunoblot of lysates prepared from cells subjected to prolonged exposure (6 or 24 h, as indicated) to TPA (ϩ; 100 nM) vs. no TPA before control treatment or treatment with NaCl (Ϫ; 100 mM ϫ 15 min). B: reporter gene assay of cells transfected with a luciferase reporter construct driven by the murine Egr-1 proximal 5Ј-flanking sequence (Egr-1-Luc) or by tandem repeats of the tonicity-responsive TonE enhancer element (BGT-2X-Luc), then subjected to 24-h pretreatment with TPA (100 nM) or no pretreatment as indicated, and, last, exposed to the indicated concentrations of urea or NaCl. TPA pretreatment (PKC downregulation) partially blocked the effect of urea on Egr-1 transcription [positive control; as previously shown (5)] but failed to influence the effect of hypertonic NaCl on TonE-dependent transcription. might be involved, as it is a rottlerin-sensitive process, whereas other data showed that tonicity signaling was insensitive to PKC downregulation. Additional studies were undertaken to determine the role of PKC␦ activation in the tonicity-inducible transcription. A series of PC-12 cell lines were used that constitutively overexpress dominant negative-acting truncation mutants of nPKC␦ and nPKC⑀ isoforms or empty vector alone. These cell lines exhibited dramatically downregulated PKC␦ and PKC⑀ activity in other experimental contexts (8, 14, 15, 34) . Initially, a degree of hypertonic stress was established at which tonicity-dependent transcription could be demonstrated in this PC-12 model. Hypertonic stress (800 mosmol/kgH 2 O NaCl) increased ERK dual phosphorylation at 15 min of treatment in untransfected PC-12 cells (Fig. 6A) , consistent with earlier observations (24) . A comparable degree of induction was observed in vector-transfected PC-12 cells; however, in the PC-12 cell lines harboring dominant negative PKC␦ and PKC⑀, there was a marked diminution in the effect of hypertonicity in the absence of an effect on basal levels of ERK activation (Fig. 6A) . There was no effect on p38 activation in response to hypertonicity. It was concluded that the dominant negative PKC isoforms were effectively inhibiting nPKC-dependent signaling in this model, consistent with the findings of Zhuang et al. (45) in the 3T3 cell line.
Next, the role of nPKC in tonicity-dependent transcription, in contrast to ERK activation, was examined in this validated PC-12 cell model. Cells were transfected with a luciferase reporter gene, under the control of tandem copies of the TonE enhancer element cloned upstream of a thymidine kinase promoter, and then exposed to hypertonic NaCl for 6 h. In both wildtype PC-12 cells and in PC-12 cells stably transfected with vector alone, tonicity-dependent transcription was increased approximately six-to sevenfold relative to control (Fig. 6B) , consistent with observations with this construct in other cell lines (38) . Interestingly, in the cell lines expressing dominant negative PKC␦ and PKC⑀, there was no inhibitory effect on TonE-mediated transcription (expressed as fold-induction), arguing against a role for nPKC in this process. (Of note, there was substantial variation in the basal level of TonEBPdependent transcription between cell lines whereas the fold induction remained unchanged.) To corroborate that rottlerin was effective in this model as well, both wild-type and dominant negative PKC␦-expressing PC-12 cell lines were exposed to hypertonicity, in the presence or absence of rottlerin pretreatment. Again, as in the mIMCD3 cell model, rottlerin effectively abrogated tonicity-dependent transcription in both wild-type and dominant negative nPKC-expressing PC-12 cell lines (Fig. 6C) .
Phosphorylation accompanies activation of PKC isoforms; the effect of hypertonic stress on phosphorylation of PKC␦ (Thr 505 ) was examined in the mIMCD3 Fig. 6 . Effect of rottlerin on tonicity-dependent transcription is independent of novel isoforms PKC␦ and PKC⑀. A: the PC-12 cell model was used to establish the contribution of novel PKC isoforms to tonicity-dependent signaling. The ability of hypertonic stress to activate ERK phosphorylation was examined in control PC-12 cells and in cell lines overexpressing dominant-negative (DN) PKC␦, DN-PKC⑀, or empty vector alone. The effect of control treatment (C) or hypertonic stress (H) on ERK phosphorylation (filled arrowheads) in each of these cell lines is depicted in the top panel; the effect on p38 phosphorylation via anti-P-p38 immunoblotting is depicted in the bottom panel. B: effect of hypertonic stress on TonE-dependent transcription of a luciferase reporter gene in PC-12 cells and in PC-12-based stably transfected cell lines. Despite a substantial decrement in basal (Control) TonEBPdependent transcription in all of the transfected cell lines, there were no significant differences in the fold-induction in response to hypertonic stress (fold-induction relative to control for each pretreatment pair depicted numerically at base of filled bars). C: effect of rottlerin pretreatment on tonicity-dependent reporter gene expression in parental PC-12 cells and stable transfectants expressing DN-PKC␦. Rottlerin was effective in both contexts.
cell model as an additional correlate of PKC␦ activation (22) . Although TPA treatment increased PKC␦ phosphorylation in a time-dependent fashion, no effect of NaCl treatment relative to time 0 could be demonstrated (Fig. 7) .
In the aggregate, these data strongly supported the absence of a role for PKC␦ in tonicity signaling to ERK activation and TonE-dependent transcription in renal medullary cells. Atypical isoforms PKC and PKC (PKC is the murine homolog of PKC) are insensitive to downregulation with protracted TPA treatment; it was therefore hypothesized that one of these isoforms may be involved in rottlerin-sensitive tonicity signaling. RT-PCR analysis was performed with poly-A ϩ RNA prepared from mIMCD3 cells to determine which isoforms were expressed in these cells. PKC␦, PKC⑀, PKC, and PKC, as well as the related kinase PRK1, were all expressed in renal medullary cells (Fig. 8) . Of the atypical isoforms, only PKC has been widely studied. In addition, only PKC␣, PKC␦, and PKC appear to be widely expressed. Furthermore, because PKC is not downregulated by protracted TPA treatment and does not necessarily undergo translocation in the setting of activation, it was a reasonable candidate for mediating the effect of hypertonicity on TonE-dependent transcription. The inhibitor Go-6983 is reported to inhibit PKC (11); however, this compound failed to abrogate the effect of hypertonic NaCl on tonicitydependent transcription by reporter gene assay (data not shown). The only PKC isoform unaffected by Go-6983 is PKC (11), more commonly known as protein kinase D (PKD) (31) . The cPKC-directed inhibitor Go-6976 is also a potent PKC inhibitor (11) , yet it failed to influence TonEBP-dependent transcription (Fig. 2 and data not shown).
DISCUSSION
Recent evidence supports a role for PKC␦ in hypertonic stress signaling. Zhuang et al. (45) described the sensitivity of tonicity-inducible ERK activation to both the putative PKC␦-specific inhibitor rottlerin and to PKC downregulation (45) . In addition, membrane translocation of the PKC␦ isoform was detected. Although no other data have implicated nPKC isoforms per se, others have described an inhibitory effect of PKC downregulation (affecting both novel and conventional isoforms) on hypertonic signaling to ERK activation (16, 20, 21, 33, 36) . We attempted to extend this observation to transcriptional events engendered by hypertonic stress and uncovered a discrepancy between rottlerin sensitivity and PKC␦ dependence. Rottlerin dramatically suppressed TonEBP-dependent transcription, apparently by inhibiting the tonicity-dependent increment in TonEBP expression at the mRNA and protein level. Interestingly, another PKC␦ inhibitor, GF-109203, also suppressed tonicity-mediated transcription but failed to abrogate TonEBP expression. Most importantly, through a combination of biochemical and dominant-negative approaches, hypertonicity-inducible TonEBP-mediated transcription was found to be independent of PKC␦ or PKC⑀ activation.
It is puzzling that two inhibitors with purportedly similar mechanisms of action should operate at distinct loci in the same signaling pathway. It is possible that the effect of rottlerin and GF-109203X overlap in terms of TonEBP-dependent transcription but that rottlerin exhibits an additional and independent effect on TonEBP expression. GF-109203X reportedly exhibits greater potency with respect to conventional PKC isoforms than novel ones; nonetheless, inhibitors of classic PKC (e.g., Go-6976 and PKC downregulation with protracted TPA treatment) failed to influence TonEBP-dependent signaling. It is also possible that regulation of the TonE-dependent reporter might differ in some respects from that of the native aldose reductase gene.
Beyond PKC␦, present data also refute a role for any known PKC isoforms in mediating tonicity-de- Fig. 7 . Hypertonic stress fails to activate PKC␦ in mIMCD3 cells. Whole cell detergent lysates were prepared from control-treated cells or from cells treated for the indicated interval (in min) with the indicated concentration of NaCl or with TPA (100 nM) and then subjected to immunoblotting with anti-P-(Thr 505 ) PKC␦. Fig. 8 . Renal medullary cells express other atypical and related PKC isoforms. Poly-A ϩ RNA from mIMCD3 was subjected to RT-PCR using primers specific for PKC␦, PKC⑀, PKC, and PKC, and the PKC-related kinase PRK1 (see METHODS); resultant products were resolved, stained with ethidium bromide, and visualized by fluorescence. PCR products of the expected size were detected for each of the 5 kinases. The order of the gel lanes has been digitally modified, and several intervening lanes have been deleted; however, all lanes are derived from the same gel and are depicted at the same scale and exposure. L, ladder. pendent transcription in renal medullary cells. PKC downregulation with prolonged phorbol ester treatment failed to influence TonEBP-dependent signaling; hence, the cPKC (␣, ␤ I , ␤ II , and ␥) and nPKC (␦, ⑀, , ) isoforms are unlikely to be involved. The atypical isoforms PKC and PKC may be TPA insensitive, and both are expressed in mIMCD3 cells (data herein and Ref. 4); the former isoform, unlike TonEBP-dependent transcription, is sensitive to Go-6983, whereas few data are available regarding PKC translocation or inhibitor sensitivity. PKC (PKD) should be sensitive to Go-6976, whereas TonEBP-dependent transcription is not. PRK1, the related kinase, is expressed in mIMCD3 cells; however, as for PKC, limited data are available with respect to pharmacological inhibition. In the aggregate, these data argue against a role for any PKC isoform in this process in renal medullary cells, although involvement of PKC or a PKC-related kinase cannot be fully excluded on the basis of available data and reagents. This is in marked contrast to the observations of Zhuang et al. (45) , who noted, in the fibroblastic 3T3 cell model, that both rottlerin and protracted phorbol ester treatment abrogated tonicity-dependent signaling to ERK activation, findings consistent with bona fide involvement of PKC.
These observations with rottlerin extend the small list of pharmacological inhibitors known to influence TonEBP-dependent signal transduction. Activation of the p38 MAPK has been variably implicated in TonEBP expression or function (19, 32) as has proteasomal processing (41) ; inhibition of these pathways abrogates TonEBP-dependent signaling. We have shown that pretreatment with the membranepermeant renal medullary solute urea (200 mM), but not the permeant solute glycerol, blocks hypertonic stress-inducible TonEBP mRNA expression and Ton-EBP-dependent transcription (38) . The mechanism through which rottlerin is acting in the present context, independently of PKC␦, is unclear. Rottlerin blocks TonEBP mRNA expression at an early time point and, because the tonicity-dependent increase in TonEBP mRNA is not a consequence of altered mRNA stability (40) , rottlerin would appear to block TonEBP transcription. No data are available with regard to signaling events related to TonEBP transcription per se.
Although rottlerin does not appear to mediate its effect on tonicity-dependent signaling through PKC, we demonstrated expression of PKC␦, PKC⑀, PKC, and PKC, as well as the related PRK1 kinase, in the mIMCD3 murine inner medullary cell line. These data are consistent with and extend the observations of others. Ostlund et al. (29) detected renal expression of PKC␣, PKC␦, PKC⑀, and PKC via a combination of approaches. Aristimuno and Good (1) noted immunodetectable PKC␣, PKC␤ II , PKC␦, PKC⑀, and PKC in the inner stripe of the outer medulla and medullary thick ascending limb, as well as agonist-inducible membrane translocation of PKC␦. Chou et al. (4) , in contrast, examining inner medullary collecting duct suspensions, noted agonist-inducible translocation of only the PKC isoform. In this latter model, which likely bears the closest relation to the mIMCD3 cell culture system, expression of PKC␣, PKC␦, PKC⑀, PKC, and PKC was demonstrated via immunoblotting (4) .
In summary, the putative PKC␦-specific inhibitor, rottlerin, blocks tonicity-dependent transcription and tonicity-dependent expression of the TonEBP transcription factor, but does so in a PKC␦-independent fashion. These data establish a potentially useful pharmacological inhibitor of TonEBP expression and TonEBP-dependent signaling and call into question the presumed specificity of rottlerin action.
